mutation3D: Cancer Gene Prediction Through Atomic Clustering of Coding Variants in the Structural Proteome

Human Mutation

Volumn 37, Issue 5, 2016, Pages 447-456

  Meyer, Michael J ^a,b,c   Lapcevic, Ryan ^a,b   Romero, Alfonso E ^d   Yoon, Mark ^a,b   Das, Jishnu ^a,b   Beltrán, Juan Felipe ^a,b   Mort, Matthew ^e   Stenson, Peter D ^e   Cooper, David N ^e   Paccanaro, Alberto ^d   Yu, Haiyuan ^a,b  

^a Program on Infrastructure Policy   (United States)

^b School of Integrative Plant Sciences   (United States)

^c Tri Institutional Training Program in Computational Biology and Medicine   (United States)

^d UNIVERSITY OF LONDON   (United Kingdom)

^e CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Cancer; Clustering; Protein structures; Somatic mutations; Web tool

Indexed keywords

AROMATASE; GUANOSINE TRIPHOSPHATASE; K RAS PROTEIN; PROTEIN VARIANT; PROTEOME;

AMINO ACID SUBSTITUTION; ARTICLE; CODING; CRYSTAL STRUCTURE; EXOME; FEASIBILITY STUDY; GENE MUTATION; GENETIC VARIABILITY; GENOME; HUMAN; NEOPLASM; PRIORITY JOURNAL; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TUMOR GENE; ALGORITHM; CHEMISTRY; CLUSTER ANALYSIS; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; PROTEIN TERTIARY STRUCTURE; WEB BROWSER;

ALGORITHMS; AMINO ACID SUBSTITUTION; CLUSTER ANALYSIS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; PROTEOME; WEB BROWSER;

EID: 84959111658     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22963     Document Type: Article

References (41)

1. Adzhubei I, Schmidt S, Peshkin L, Ramensky V, Gerasimova A, Bork P, Kondrashov A, Sunyaev S. 2010. A method and server for predicting damaging missense mutations. Nat Methods 7:248-249.
2. Alexandrov L, Nik-Zainal S, Wedge D, Aparicio S, Behjati S, Biankin A, Bignell G, Bolli N, Borg A, Børresen-Dale A-L, Boyault S, Burkhardt B, et al. 2013. Signatures of mutational processes in human cancer. Nature 500:415-421.
3. Berman HM. 2000. The Protein Data Bank. Nucleic Acids Res 28:235-242.
4. Cancer Genome Atlas N. 2012. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487:330-337.
5. Das J, Fragoza R, Lee HR, Cordero NA, Guo Y, Meyer MJ, Vo TV, Wang X, Yu H. 2014a. Exploring mechanisms of human disease through structurally resolved protein interactome networks. Mol Biosyst 10:9-17.
6. Das J, Lee HR, Sagar A, Fragoza R, Liang J, Wei X, Wang X, Mort M, Stenson PD, Cooper DN, Yu H. 2014b. Elucidating common structural features of human pathogenic variations using large-scale atomic-resolution protein networks. Hum Mutat 35:585-593.
7. Forbes S, Bindal N, Bamford S, Cole C, Kok C, Beare D, Jia M, Shepherd R, Leung K, Menzies A, Teague J, Campbell P, et al. 2011. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 39:50.
8. Fu W, O'Connor T, Jun G, Kang H, Abecasis G, Leal S, Gabriel S, Rieder M, Altshuler D, Shendure J, Nickerson D, Bamshad M, et al. 2013. Analysis of 6, 515 exomes reveals the recent origin of most human protein-coding variants. Nature 493:216-220.
9. Futreal P, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton M. 2004. A census of human cancer genes. Nat Rev Cancer 4:177-183.
10. Grantham R. 1974. Amino acid difference formula to help explain protein evolution. Science 185:862-864.
11. Guedes J, Veiga I, Rocha P, Pinto P, Pinto C, Pinheiro M, Peixoto A, Fragoso M, Raimundo A, Ferreira P, Machado M, Sousa N, et al. 2013. High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer. BMC Cancer 13:169.
12. Hanahan D, Weinberg R. 2011. Hallmarks of cancer: the next generation. Cell 144:646-674.
13. Hodis E, Watson I, Kryukov G, Arold S, Imielinski M, Theurillat J-P, Nickerson E, Auclair D, Li L, Place C, Dicara D, Ramos A, et al. 2012. A landscape of driver mutations in melanoma. Cell 150:251-263.
14. Kamburov A, Lawrence MS, Polak P, Leshchiner I, Lage K, Golub TR, Lander ES, Getz G. 2015. Comprehensive assessment of cancer missense mutation clustering in protein structures. Proc Natl Acad Sci USA 112:E5486-E5495.
15. Kan Z, Jaiswal B, Stinson J, Janakiraman V, Bhatt D, Stern H, Yue P, Haverty P, Bourgon R, Zheng J, Moorhead M, Chaudhuri S, et al. 2010. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466:869-873.
16. Kucukkal TG, Petukh M, Li L, Alexov E. 2015. Structural and physico-chemical effects of disease and non-disease nsSNPs on proteins. Curr Opin Struct Biol 32:18-24.
17. Lawrence M, Stojanov P, Mermel C, Robinson J, Garraway L, Golub T, Meyerson M, Gabriel S, Lander E, Getz G. 2014. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505:495-501.
18. Lawrence M, Stojanov P, Polak P, Kryukov G, Cibulskis K, Sivachenko A, Carter S, Stewart C, Mermel C, Roberts S, Kiezun A, Hammerman P, et al. 2013. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499:214-218.
19. McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F. 2010. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 26:2069-2070.
20. Miller M L, Reznik E, Gauthier Nicholas P, Aksoy Bülent A, Korkut A, Gao J, Ciriello G, Schultz N, Sander C. 2015. Pan-cancer analysis of mutation hotspots in protein domains. Cell Syst 1:197-209.
21. Muller P, Vousden K. 2013. p53 mutations in cancer. Nat Cell Biol 15:2-8.
22. Nishi H, Tyagi M, Teng S, Shoemaker BA, Hashimoto K, Alexov E, Wuchty S, Panchenko AR. 2013. Cancer missense mutations alter binding properties of proteins and their interaction networks. PLoS One 8:e66273.
23. Petukh M, Kucukkal TG, Alexov E. 2015. On human disease-causing amino acid variants: statistical study of sequence and structural patterns. Hum Mutat 36:524-534.
24. Pieper U, Webb B, Barkan D, Schneidman-Duhovny D, Schlessinger A, Braberg H, Yang Z, Meng E, Pettersen E, Huang C, Datta R, Sampathkumar P, et al. 2011. ModBase, a database of annotated comparative protein structure models, and associated resources. Nucleic Acids Res 39:74.
25. Pylayeva-Gupta Y, Grabocka E, Bar-Sagi D. 2011. RAS oncogenes: weaving a tumorigenic web. Nat Rev Cancer 11:761-774.
26. Ryslik GA, Cheng Y, Cheung K-HH, Modis Y, Zhao H. 2012. Utilizing protein structure to identify non-random somatic mutations. BMC Bioinformatics 14:190.
27. Ryslik GA, Cheng Y, Cheung K-HH, Modis Y, Zhao H. 2014. A graph theoretic approach to utilizing protein structure to identify non-random somatic mutations. BMC Bioinformatics 15:86.
28. Schrodinger LLC. 2010. The PyMOL Molecular Graphics System, Version 1.3r1. Available at: https://www.pymol.org/.
29. Sjöblom T, Jones S, Wood L, Parsons D, Lin J, Barber T, Mandelker D, Leary R, Ptak J, Silliman N, Szabo S, Buckhaults P, et al. 2006. The consensus coding sequences of human breast and colorectal cancers. Science 314:268-274.
30. Sneath P. 1957. The application of computers to taxonomy. J Gen Microbiol 17:201-226.
31. Sørensen T. 1948. A method of establishing groups of equal amplitude in plant sociology based on similarity of species and its application to analyses of the vegetation on Danish commons. Biol Skr 5:1-34.
32. Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN. 2014. The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet 133:1-9.
33. Tamborero D, Gonzalez-Perez A, Lopez-Bigas N. 2013. OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes. Bioinformatics 29:2238-2244.
34. Tusche C, Steinbruck L, McHardy AC. 2012. Detecting patches of protein sites of influenza A viruses under positive selection. Mol Biol Evol 29:2063-2071.
35. Velankar S, Dana J, Jacobsen J, van Ginkel G, Gane P, Luo J, Oldfield T, O'Donovan C, Martin M-J, Kleywegt G. 2013. SIFTS: Structure Integration with Function, Taxonomy and Sequences resource. Nucleic Acids Res 41:9.
36. Vucic E, Thu K, Robison K, Rybaczyk L, Chari R, Alvarez C, Lam W. 2012. Translating cancer 'omics' to improved outcomes. Genome Res 22:188-195.
37. Wagner A. 2007. Rapid detection of positive selection in genes and genomes through variation clusters. Genetics 176:2451-2463.
38. Wang X, Wei X, Thijssen B, Das J, Lipkin SM, Yu H. 2012. Three-dimensional reconstruction of protein networks provides insight into human genetic disease. Nat Biotechnol 30:159-164.
39. Wei X, Das J, Fragoza R, Liang J, Bastos de Oliveira FM, Lee HR, Wang X, Mort M, Stenson PD, Cooper DN, Lipkin SM, Smolka MB, et al. 2014. A massively parallel pipeline to clone DNA variants and examine molecular phenotypes of human disease mutations. PLoS Genet 10:e1004819.
40. Wood L, Parsons D, Jones S, Lin J, Sjöblom T, Leary R, Shen D, Boca S, Barber T, Ptak J, Silliman N, Szabo S, et al. 2007. The genomic landscapes of human breast and colorectal cancers. Science 318:1108-1113.
41. Zhou T, Enyeart PJ, Wilke CO. 2008. Detecting clusters of mutations. PLoS One 3:e3765.